Artelo Biosciences, Inc. Liquidation Value
ARTL
Other
Cash & Equivalents
$600,000
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $600,000
Total Obligations: -$4.11M
$-3.51M
Per share: $-1.74
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $600,000
AR: $0
Total Obligations: -$4.11M
$-3.51M
Per share: $-1.74
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $600,000
AR: $0
Inventory: $0
Total Obligations: -$4.11M
$-3.51M
Per share: $-1.74
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $-3.51M | $-1.74 |
| Liquid Liquidation Value | $-3.51M | $-1.74 |
| Operating Liquidation Value | $-3.51M | $-1.74 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $600,000 |
| Accounts Receivable | N/A |
| Inventory | N/A |
| Current Liabilities | $4.04M |
| Long-term Debt | N/A |
| Op. Lease Liability | $69,000 |
| Finance Lease | N/A |
| Shares Outstanding | 2.0M |
Explore all 165 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $600,000 | N/A | N/A | N/A | $4.04M | N/A | $69,000 | N/A |
| 2025-10-28 | N/A | N/A | N/A | N/A | N/A | $692,000 | N/A | N/A |
| 2025-09-30 | $3.44M | N/A | N/A | N/A | $4.86M | N/A | $79,000 | N/A |
▼ Community Notes